Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-480
Closed -$21.8K 340
2025
Q3
$21.8K Buy
480
+1
+0.2% +$40 0.01% 531
2025
Q2
$15.2K Buy
479
+19
+4% +$544 0.01% 710
2025
Q1
$13.7K Sell
460
-262
-36% -$9.23K 0.01% 765
2024
Q4
$25.9K Sell
722
-41
-5% -$1.61K 0.01% 480
2024
Q3
$30.9K Buy
763
+1
+0.1% +$43 0.01% 399
2024
Q2
$35.6K Sell
762
-15
-2% -$660 0.02% 312
2024
Q1
$33K Buy
777
+719
+1,240% +$28K 0.02% 345
2023
Q4
$2.44K Hold
58
﹤0.01% 443
2023
Q3
$2.48K Hold
58
﹤0.01% 442
2023
Q2
$3.26K Hold
58
﹤0.01% 460
2023
Q1
$2.88K Hold
58
﹤0.01% 526
2022
Q4
$2.74K Hold
58
﹤0.01% 518
2022
Q3
$2K Hold
58
﹤0.01% 533
2022
Q2
$2K Hold
58
﹤0.01% 539
2022
Q1
$4K Hold
58
﹤0.01% 442
2021
Q4
$4.49K Buy
+58
New +$4.68K ﹤0.01% 420

Other funds holding CGNX

Rise Advisors's CGNX Position: Q4 2025 in Review

Rise Advisors sold out of Cognex (CGNX) in Q4 2025, closing a stake of 480 shares — an estimated $21.8K sold.

Rise Advisors first reported a position in CGNX in Q4 2021 and held it in 16 quarters. The position peaked at $35.6K in Q2 2024. 528 funds tracked by Wall St. Rank hold CGNX as of Q4 2025.

  • Rise Advisors reported no remaining Cognex position as of Q4 2025 after selling out during the quarter.
  • Rise Advisors sold 480 Cognex shares in Q4 2025, an estimated $21.8K.
  • Rise Advisors first reported a position in Cognex in Q4 2021 and held it in 16 quarters.
  • Rise Advisors's Cognex position peaked at $35.6K in Q2 2024.
  • 528 funds tracked by Wall St. Rank held Cognex as of Q4 2025.

Based on Rise Advisors's 13F filing for Q4 2025, filed 11 Feb 2026.